References
- [1] Markelewicz Jr RJ, Lorenzen WA, Shusterman S, et al. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131i-metaiodobenzylguanidine (131i-mIBG) therapy. Clin Nucl Med. 2013;38(8):604-607.
- [2] Tonnonchiang S, Sritongkul N, Chaudakshetrin P, Tuntawiroon M. Radiation exposure to relatives of patients treated with iodine-131 for thyroid cancer at Siriraj hospital. J Med Assoc Thai. 2016;99(2):220-224.
- [3] Gains JE, Walker C, Sullivan T, et al. Radiation exposure to comforters and carers during paediatric molecular radiotherapy. Pediatr Blood Cancer. 2015;62(2):235-239.
- [4] Cougnenc O, Defachelles A-S, Carpentier P, et al. High-dose 131i-mibg therapies in children: Feasibility, patient dosimetry and radiation exposure to workers and family caregivers. Radiat Prot Dosimetry. 2017;173(4):395-404.
- [5] de la Guardia M, Mata S, McCammon S, et al. Physician and nursing personnel radiation exposure monitoring experience during the first year of performing i-131 metaiodobenzylguanidine (mIBG) therapy. Conference: Society of Nuclear Medicine and Molecular Imaging, Baltimore, MD. J Nucl Med. 2015;56(Supplement3):1251.
- [6] Tuncel N, Karayalcin B, Koca G. The calibration process of OSL detectors used for staff and patient dosimetry in hospital environment. J Nuc Med Radiat Therapy. 2015;6(6):1000259.
- [7] Dietze G, Menzel H-G. Dose quantities in radiation protection and their limitations. Radiat Prot Dosimetry. 2004;112(4):457-463.
- [8] ICRP. The 2007 recommendations of the international commission on radiological protection: ICRP Publication 103. Ann ICRP. 2007;37(2-4).
- [9] Bartlett DT. Personal dose equivalent, Hp(d), and reference point for calibration. Radiat Prot Dosimetry. 2006;121(3):209-210.
- [10] Changmuang W, Chamroonrat W, Kositwattanarerk A, et al. Radiation from an admitted thyroid cancer patient with high dose I-131 treatment in related hospitalized area and exposure to associated personnel in Ramathibodi’s new inpatient unit. Asean J Radiol. 2012;18(2):118-122.
- [11] Wrixon AD. New ICRP recommendations. J Radiol Prot. 2008;28(2):161-168.
- [12] Chu BP, Horan C, Basu E, et al. Feasibility of administering high-dose 131I-MIBG therapy to children with high-risk neuroblastoma without lead-lined rooms. Pediatr Blood Cancer. 2016;63(5):801-807.
- [13] Assessment of occupational exposure due to intakes of radionuclides. IAEA Safety Standards Series No. RS-G-1.2. Vienna: International Atomic Energy Agency; 1999.